ConductScience.org, home

Gene · 23632

CA14: carbonic anhydrase 14

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. CA14: carbonic anhydrase 14. Genes, record 23632. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/23632

On this page

Gene

Symbol
CA14
HGNC
Name
carbonic anhydrase 14
HGNC
NCBI Gene ID
23632
NCBI Gene
HGNC ID
HGNC:1372
HGNC
Ensembl
ENSG00000118298
NCBI Gene
Aliases
CAXiV
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q9ULX7Carbonic anhydrase 143372Ensembl, GeneID, HGNC

Source UniProt

Patents246

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1440033Q9ULX7Espacenet
EP 4650780 A22025-11-198573Q9ULX7Espacenet
EP 4641201 A22025-10-298730Q9ULX7Espacenet
JP 2025529142 A2025-09-04680Q9ULX7Espacenet
US 12371689 B22025-07-29680Q9ULX7Espacenet
JP 2025517969 A2025-06-128730Q9ULX7Espacenet
JP 2025517970 A2025-06-128573Q9ULX7Espacenet
JP 2025062604 A2025-04-1411757Q9ULX7Espacenet
JP 2025032204 A2025-03-1125796Q9ULX7Espacenet
JP 2025503451 A2025-02-047Q9ULX7Espacenet

1 to 10 of 246

See all 246 patents

Drugs2

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
ETHOXZOLAMIDECHEMBL18Carbonic anhydrase inhibitorINHIBITORChEMBL
SULTHIAMECHEMBL328560Carbonic anhydrase inhibitorINHIBITORChEMBL

Trials2

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT05885646SULTHIAMEClinicalTrials.gov
NCT05236842SULTHIAMEPHASE2ClinicalTrials.gov

NIH grants196

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleCA14 papersNewest fiscal year
P01HL158502Atrial Fibrillation Post-GWAS: Mechanisms to Treatment12025
P30CA006973Regional Oncology Research Center12025
P30CA016086Cancer Center Support Grant12025
P30CA016672Cancer Center Support Grant12025
P30CA036727Buffett Cancer Center Support Grant12025
P30CA068485Cancer Center Support Grant12025
P30DK034989Yale Liver Center12025
P30DK054759Precision Medicine Center for Cystic Fibrosis12025
P30ES005605Environmental Health Sciences Research Center12025
P30ES029067Texas A&M Center for Environmental Health Research (TiCER)12025

1 to 10 of 196Source NIH's project files

See all 196 nih grants

Papers409

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Computational prioritization of candidate TCDD-associated targets in retinoblastoma using network toxicology and transcriptomic analysis.Front Genet202642775123PubTator, text miningPubMed
Phosgene inhalation injury in mice: Modeling human pathophysiology, biomarker discovery, and therapeutic target identification.Toxicol Appl Pharmacol202642575345PubTator, text miningPubMed
Carbonic anhydrase XIV.Enzymes202642486550PubTator, text miningPubMed
Carbon Dioxide Euthanasia Selectively Affects Physiology of Murine Retinal Cells, Implicating Carbonic Anhydrase-Expressing Cell Populations.Invest Ophthalmol Vis Sci202641914967PubTator, text miningPubMed
Hippocampal morphometry is altered in infants with congenital heart disease.Brain Commun202641799861PubTator, text miningPubMed
Identification of MTURN as a trained immunity-related biomarker for heart failure via integrative transcriptomic machine learning analysis and experimental validation.Front Immunol202641789108PubTator, text miningPubMed
Plasma Proteomic Signatures of Physical Activity Provide Insights into Biological Impacts and its Protective Role against Dementia.Med Sci Sports Exerc202641582318PubTator, text miningPubMed
Olink Proteomic Profiling of Vitreous Humor and Plasma From Proliferative Diabetic Retinopathy Patients Identifies a Novel Inflammatory Molecular Endotype.Invest Ophthalmol Vis Sci202641563014PubTator, text miningPubMed
Proteomic signature of dementia risk in type 2 diabetes.J Adv Res202640829688PubTator, text miningPubMed
Unraveling diethyl phthalate-induced prostate carcinogenesis: core targets revealed by integrated network toxicology, machine learning, and structural validation.Hum Genomics202541444679PubTator, text miningPubMed

1 to 10 of 409

See all 409 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/23632

GET https://conductscience.org/api/genes/v1/23632/patents?page=2